Inventiva will gain a new chairman following the deal as it presses ahead with a Phase III trial for its lead asset.

Inventiva secures €94.1 million of a multi-tranche equity financing of up to €348 million, subject to satisfaction of ...

标准的芦荟汁，如丝般顺滑就是看着有点翻江倒海 ...

Wuhan YZY Biopharma Co. Ltd. is out-licensing lead candidate M-701, a CD3/EpCAM bispecific antibody, to Chia Tai Tianqing Pharmaceutical Group Co. Ltd. (CTTQ) for China rights in a deal worth up to ...